“We combine health actives, biotics and formulation expertise to turn robust science into differentiated solutions for our customers and consumers. SupplySide Global gives us a strong platform to advance this integrated proposition in the Americas and across global markets,” says Isabelle Ducellier, Global VP Health at Symrise Care & Wellness.
New clinical results for Acerowell™
At the trade show, Symrise will present new clinical evidence for Acerowell™, its premium acerola-based ingredient for beauty-from-within formulations. In a randomized, placebo-controlled study of 108 women aged 45 to 60, daily supplementation with 600 mg for 12 weeks significantly improved skin radiance and translucency versus placebo. More than 80% of participants also reported improvements in skin luminosity, complexion and texture.
Symrise standardizes and vertically integrates the acerola powder for consistent quality and traceability. Manufacturers can use Acerowell™ in powders, gummies and functional beverages, combining formulation flexibility with clinically supported visible results from the first month.
Postbiotic Rham271h™ expands the possibilities for biotic innovation
With its postbiotic Rham271h™ on display, Symrise demonstrates how science-backed postbiotics can broaden formulation opportunities beyond live probiotics. Probi derives the ingredient from Lacticaseibacillus rhamnosus 6594. The inactivated strain retains biological activity, while its pH and heat resistance support stable, versatile applications. In-vitro research indicates effects on biomarkers associated with immune modulation, including increased levels of the anti-inflammatory cytokine IL-10, as well as support for gut barrier integrity.
At a daily dose of 10 billion TFU, Rham271h™ offers manufacturers a stable option for dietary supplements and functional foods and beverages. It also advances Probi’s strategy to build a broader platform across prebiotics, probiotics, synbiotics and postbiotics supporting differentiated microbiome solutions for specific formulation and consumer needs.
Clinical study highlights targeted probiotic benefits for digestive health
Visitors can explore new clinical evidence for LP299V® and LPGOS42™. It further supports Probi’s strain-specific approach. In an eight-week randomized, placebo-controlled study of 100 healthy adults with occasional constipation, the dual-strain combination significantly improved key measures of digestive comfort and regularity, along with quality-of-life outcomes, versus placebo.
A post-hoc analysis provided further insight into participants who reported three or fewer weekly bowel movements at baseline, representing 80% of the study population. In this group, the dual-strain formulation achieved a significantly greater increase in weekly complete spontaneous bowel movements. The results support the development of targeted probiotic solutions and extend the evidence for LP299V® across digestive health, sports and active nutrition.
A broader platform for science-backed health
Together, the three showcases demonstrate how Symrise combines clinically supported ingredients, complementary biotic technologies and application expertise across Women’s Health, Longevity, Digestive Health, and Sports & Active Nutrition. This integrated approach advances the ONE Symrise strategy and helps customers translate evolving health and wellness needs into differentiated products.
At its booth, Symrise will present formulation concepts, recipes and taste-balancing solutions in beverages, stick packs and chewables. These market-ready applications demonstrate how Symrise transforms science-backed ingredients into accessible, enjoyable consumer experiences.
The first joint Americas presence of Probi and Health Active Solutions gives customers integrated access to complementary scientific, formulation and application expertise. Together, these capabilities strengthen Symrise Care & Wellness as a science-driven partner for next-generation nutrition, health and wellness products.
The Symrise team will welcome discussions at Booth 2364 on consumer health trends, the latest clinical evidence and opportunities for science-backed nutrition and wellness innovation. Meetings can be scheduled here.
